Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.790
-0.140 (-7.25%)
At close: Feb 11, 2026, 4:00 PM EST
1.800
+0.010 (0.56%)
After-hours: Feb 11, 2026, 6:11 PM EST
Century Therapeutics Revenue
Century Therapeutics had revenue of $113.34M in the twelve months ending September 30, 2025, up 4,122.69% year-over-year. In the year 2024, Century Therapeutics had annual revenue of $6.59M with 194.81% growth.
Revenue (ttm)
$113.34M
Revenue Growth
+4,122.69%
P/S Ratio
1.36
Revenue / Employee
$755,580
Employees
150
Market Cap
321.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.59M | 4.35M | 194.81% |
| Dec 31, 2023 | 2.24M | -2.96M | -57.01% |
| Dec 31, 2022 | 5.20M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionIPSC News
- 2 days ago - Century Therapeutics: A Very Promising Contender In The Type I Diabetes Mellitus Functional Cure Race - Seeking Alpha
- 2 months ago - Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes - GlobeNewsWire
- 4 months ago - Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference - GlobeNewsWire
- 6 months ago - Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 6 months ago - Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 9 months ago - Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress - GlobeNewsWire